Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Corteva raises 2021 sales forecast on strong demand for herbicides, insecticides

05/04/2021 | 05:00pm EDT
The logo and trading info for Corteva Agriscience, a former division of DowDuPont, is displayed on a screen at the NYSE in New York

May 4 (Reuters) - Pesticide and seed maker Corteva Inc on Tuesday reported better-than-expected profit and revenue and raised its net sales forecast for the year, helped by strong demand for its herbicides and insecticides.

The company, spun off in 2019 after a merger of Dow Chemical and Dupont, has laid off employees and retired some assets to cut costs as it faces increased competition in North America, a weaker Brazilian real and sharper focus from shareholders after a battle with activist investor Starboard Value LP.

First-quarter net sales rose 6%, with strong demand for its new products including Arylex, Enlist and Rinskor herbicides and Isoclast and Pyraxal insecticides.

Record corn and sunflower volume in Europe, Middle East and Africa regions, along with strong Safrinha sales in Brazil buoyed seed sales.

Corteva said it now expects net sales for the full year to range between $14.6 billion and $14.8 billion, compared to between $14.4 billion and $14.6 billion forecast earlier.

The company reaffirmed its expectation for operating earnings to range between $1.85 and $1.95 per share.

Corteva, however, warned that it experienced cost increases in freight and logistics, as well as raw materials, as global economies reopen after the COVID-19 pandemic.

Operating earnings per share of 79 cents for the first quarter beat estimates of 65 cents, while organic sales of $4.20 billion surpassed the $3.81 billion expected by analysts. (Reporting by Arathy S Nair in Bengaluru; Editing by Sriraj Kalluvila)


ę Reuters 2021
Latest news "Economy & Forex"
01:26pBank of England's Haskel 'not that worried' by inflation
RE
01:24pU.S. fuel shortages worsen on Day Six of pipeline outage
RE
01:24pPfizer COVID-19 vaccine works for adolescents, U.S. CDC panel told
RE
01:22pOntario regulator extends suspension of trading in Bridging Finance securities
RE
01:17pCitigroup fails to obtain longer freeze on botched Revlon transfer
RE
01:16p'Do not fill plastic bags with gasoline' U.S. warns as shortages grow
RE
01:13pBP shareholder vote shows increased support for tougher climate targets
RE
01:09pExclusive-ValueAct takes stake in 7-Eleven owner, says changes could boost share price
RE
01:05pPipeline operator Energy Transfer mulls chemicals acquisition -chairman
RE
01:05pBrazil biomedical center says shipment of Chinese vaccine ingredients delayed
RE
Latest news "Economy & Forex"